AI Insight
Scientists are developing alternative drug screening methods using organ-on-a-chip devices and organoids that can provide more accurate safety data than traditional animal testing. These advanced in vitro systems replicate human organ function and tissue behavior, potentially reducing the need for animal experiments in pharmaceutical development. The technology represents a significant shift toward more reliable pre-clinical testing that better predicts human responses to new drugs.
Why it matters
This advancement could substantially reduce animal use in drug development while simultaneously improving the accuracy of safety predictions for human patients. The adoption of these technologies may accelerate drug development timelines and reduce costs associated with failed clinical trials due to species differences between animal models and humans.
Understand the Science
Scientists can now get more accurate safety data by testing drugs on organ-on-a-chip devices and organoids, meaning that there’s increasingly less need to harm animals
Source: How better ways of screening drugs could soon lead to thousands fewer animal tests